129 related articles for article (PubMed ID: 12483365)
1. In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF).
Faulhaber M; Wörmann B; Ganser A; Verbeek W
Ann Hematol; 2002 Dec; 81(12):695-700. PubMed ID: 12483365
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia.
Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK
Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons.
Andrews RG; Winkler A; Myerson D; Briddell RA; Knitter GH; McNiece IK; Hunt P
Stem Cells; 1996 Nov; 14(6):661-77. PubMed ID: 8948024
[TBL] [Abstract][Full Text] [Related]
4. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
5. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
[TBL] [Abstract][Full Text] [Related]
6. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.
Choi ES; Hokom MM; Chen JL; Skrine J; Faust J; Nichol J; Hunt P
Br J Haematol; 1996 Nov; 95(2):227-33. PubMed ID: 8904874
[TBL] [Abstract][Full Text] [Related]
7. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
Marisavljević D; Rolović Z; Mitrović D
Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637
[TBL] [Abstract][Full Text] [Related]
8. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.
Harker LA; Hunt P; Marzec UM; Kelly AB; Tomer A; Hanson SR; Stead RB
Blood; 1996 Mar; 87(5):1833-44. PubMed ID: 8634430
[TBL] [Abstract][Full Text] [Related]
9. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia.
Adams JA; Liu Yin JA; Brereton ML; Briggs M; Burgess R; Hyde K
Br J Haematol; 1997 Oct; 99(1):139-46. PubMed ID: 9359514
[TBL] [Abstract][Full Text] [Related]
10. In vitro expansion of human megakaryocytes as a tool for studying megakaryocytic development and function.
Majka M; Baj-Krzyworzeka M; Kijowski J; Reca R; Ratajczak J; Ratajczak MZ
Platelets; 2001 Sep; 12(6):325-32. PubMed ID: 11672471
[TBL] [Abstract][Full Text] [Related]
11. Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow.
Psyllaki M; Damianaki A; Gemetzi C; Pyrovolaki K; Eliopoulos GD; Papadaki HA
Br J Haematol; 2006 Sep; 134(6):624-31. PubMed ID: 16938119
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin and myelodysplastic syndromes.
Ogata K; Tamura H
Int J Hematol; 2000 Aug; 72(2):173-7. PubMed ID: 11039665
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human megakaryocyte growth and development factor (MGDF) increases the numbers of megakaryocyte progenitor cells to normal values in long-term bone marrow cultures of patients with AML in first remission.
Kasper C; Schwarzer A; De Wynter EA; Chang J; Dexter TM; Ryder D; Testa NG
Leukemia; 1998 Jun; 12(6):907-11. PubMed ID: 9639419
[TBL] [Abstract][Full Text] [Related]
14. A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization.
Arnold JT; Daw NC; Stenberg PE; Jayawardene D; Srivastava DK; Jackson CW
Blood; 1997 Feb; 89(3):823-33. PubMed ID: 9028313
[TBL] [Abstract][Full Text] [Related]
15. The effect of decitabine on megakaryocyte maturation and platelet release.
Wang J; Yi Z; Wang S; Li Z
Thromb Haemost; 2011 Aug; 106(2):337-43. PubMed ID: 21713321
[TBL] [Abstract][Full Text] [Related]
16. Role of beta(1)-integrins and their associated tetraspanin molecules in fibronectin-enhanced megakaryopoiesis.
Han P; Guo X; Story C
Cytotherapy; 2004; 6(5):465-75. PubMed ID: 15512913
[TBL] [Abstract][Full Text] [Related]
17. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis.
Neumann TA; Foote M
Cytokines Cell Mol Ther; 2000 Mar; 6(1):47-56. PubMed ID: 10976539
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
20. Cytokines for the treatment of thrombocytopenia.
Ciurea SO; Hoffman R
Semin Hematol; 2007 Jul; 44(3):166-82. PubMed ID: 17631181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
